Exclusive: Drugs to treat stroke and schizophrenia patients could be hit if suppliers no longer see them as commercially viable
Notifications can be managed in browser preferences.
Swipe for next article
The Independent's journalism is supported by our readers. When you purchase through links on our site, we may earn commission.
Exclusive: Drugs to treat stroke and schizophrenia patients could be hit if suppliers no longer see them as commercially viable
Removed from bookmarks
Limited access to new treatments and slow research pipelines in Britain are pushing patients to take financial risks to fund…
The UK government recently added aspirin to its export ban list to protect supplies
The NHS can offer more treatments for cancer than ever before, but clinicians warn that staff shortages mean patients cannot get…
The reassurance comes after the National Pharmacy Association said that pharmacists had seen “evidence of escalating price rises”
More than a dozen cancer patients have either died or become seriously ill after not getting rasburicase
Sir Jim Mackey said NHS chiefs were ‘really worried’ about supply issues following disruption caused by the Iran war
